ANOS1: a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1.
de Castro, Fernando
Group of HGNC consultants for KAL1 nomenclature,
Briefings in Functional Genomics
Oxford University Press
MetadataShow full item record
de Castro, F., Seal, R., Maggi, R., & Group of HGNC consultants for KAL1 nomenclature,. (2017). ANOS1: a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1.. Briefings in Functional Genomics, 16 (4), 205-210. https://doi.org/10.1093/bfgp/elw037
It is accepted that confusion regarding the description of genetic variants occurs when researchers do not use standard nomenclature. The Human Genome Organization Gene Nomenclature Committee contacted a panel of consultants, all working on the KAL1 gene, to propose an update of the nomenclature of the gene, as there was a convention in the literature of using the 'KAL1' symbol, when referring to the gene, but using the name 'anosmin-1' when referring to the protein. The new name, ANOS1, reflects protein name and is more transferrable across species.
: Kallmann, ANOS1, KAL1, anosmin-1, gene, nomenclature, Animals, Extracellular Matrix Proteins, Humans, Kallmann Syndrome, Nerve Tissue Proteins, Terminology as Topic
This work was supported by grants from the Spanish Ministerio de Economia y Competitividad-MINECO (SAF2012-40023 and RD12-0032-12) and Consejo Superior de Investigaciones Científicas-CSIC (CSIC-2015201023) to F.dC., from National Human Genome Research Institute (U41HG003345) and Wellcome Trust (099129/Z/12/Z) to R.S. and from Fondazione Telethon (E.523) and Ministero dell’Istruzione Universitá e Ricerca (MIUR) to R.M
External DOI: https://doi.org/10.1093/bfgp/elw037
This record's URL: https://www.repository.cam.ac.uk/handle/1810/302569
Attribution-NonCommercial 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc/4.0/